Years ago Nasrat said he would hit up investor conferences back when SequestOx was on verge of FDA decision. Since that never occurred, Elite became a generic company and it took time to pivot. If Elite does actually pursue an exchange upgrade, there is nothing better than to start getting your name out there to educate investors and creating a pipeline. Looking forward to 2024 financial results as he redirected talk of a stock repurchase program that he has ignored for years. Let’s see when financials will dictate that will be feasible.
News 
Market Data 
Discover 
